$1.68
0.2820.43%
Last update: Nov 6, 4:27 PM
NeuroSense Therapeutics Ltd
NRSNNASDAQ
The average analyst price target for NeuroSense Therapeutics is $170, 10728.0% above the current price. Of 4 analysts, 2 rate it Buy and 2 Hold. Targets range from $60 to $280. The latest change came on Nov 2, 2026, when HC Wainwright & Co. downgraded NeuroSense Therapeutics from Buy to Neutral.
Price Target Range — 6 Quarters
Analyst Consensus — 4 Analysts
Rating Trend — Last 9 Months
